Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,818Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Aurobindo Pharma Limited

02 1Cadila Pharmaceuticals Limited

03 1Cipla Ltd.

04 1Glenmark Life Sciences Limited

05 1Honour Lab Limited

06 1Jubilant Pharmova Limited

07 1MSN Laboratories Private Limited

08 2MYLAN LABORATORIES LIMITED

09 2Viyash Life Sciences Private Limited

10 1Zydus Lifesciences Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BOSENTAN

NDC Package Code : 66039-870

Start Marketing Date : 2011-08-12

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

02

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BOSENTAN

NDC Package Code : 65862-796

Start Marketing Date : 2023-12-14

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (50kg/50kg)

Marketing Category : BULK INGREDIENT

blank

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BOSENTAN

NDC Package Code : 65691-0084

Start Marketing Date : 2013-03-05

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (25kg/25kg)

Marketing Category : BULK INGREDIENT

blank

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BOSENTAN

NDC Package Code : 53104-7703

Start Marketing Date : 2016-01-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (25kg/25kg)

Marketing Category : BULK INGREDIENT

blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BOSENTAN

NDC Package Code : 69037-0005

Start Marketing Date : 2001-11-20

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BOSENTAN

NDC Package Code : 65372-1184

Start Marketing Date : 2014-09-09

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

AACR Annual meeting
Not Confirmed
arrow

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BOSENTAN

NDC Package Code : 65015-753

Start Marketing Date : 2015-01-13

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

09

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BOSENTAN

NDC Package Code : 65015-770

Start Marketing Date : 2015-02-24

End Marketing Date : 2026-12-01

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

10

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BOSENTAN

NDC Package Code : 65841-176

Start Marketing Date : 2018-01-12

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

Looking for 147536-97-8 / Bosentan Hydrate API manufacturers, exporters & distributors?

Bosentan Hydrate manufacturers, exporters & distributors 1

53

PharmaCompass offers a list of Bosentan Hydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bosentan Hydrate manufacturer or Bosentan Hydrate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bosentan Hydrate manufacturer or Bosentan Hydrate supplier.

PharmaCompass also assists you with knowing the Bosentan Hydrate API Price utilized in the formulation of products. Bosentan Hydrate API Price is not always fixed or binding as the Bosentan Hydrate Price is obtained through a variety of data sources. The Bosentan Hydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Bosentan Hydrate

Synonyms

147536-97-8, Tracleer, Actelion, Bosentan anhydrous, Ro 47-0203, Ro-47-0203

Cas Number

147536-97-8

Unique Ingredient Identifier (UNII)

XUL93R30K2

About Bosentan Hydrate

A sulfonamide and pyrimidine derivative that acts as a dual endothelin receptor antagonist used to manage PULMONARY HYPERTENSION and SYSTEMIC SCLEROSIS.

Tracleer Manufacturers

A Tracleer manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tracleer, including repackagers and relabelers. The FDA regulates Tracleer manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tracleer API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Tracleer manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Tracleer Suppliers

A Tracleer supplier is an individual or a company that provides Tracleer active pharmaceutical ingredient (API) or Tracleer finished formulations upon request. The Tracleer suppliers may include Tracleer API manufacturers, exporters, distributors and traders.

click here to find a list of Tracleer suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Tracleer NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tracleer as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Tracleer API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Tracleer as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Tracleer and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tracleer NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Tracleer suppliers with NDC on PharmaCompass.

Tracleer Manufacturers | Traders | Suppliers

Tracleer Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.